Renaissance Technologies »

Moleculin Biotech shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 11k 2.84

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
Novo-nordisk A S Adr (NVO)
United Therapeutics Corporation (UTHR)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Verisign (VRSN)
Sprouts Fmrs Mkt (SFM)
Airbnb Com Cl A (ABNB)
NVIDIA Corporation (NVDA)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Fortinet (FTNT)
Meta Platforms Cl A (META)

View all positions for Renaissance Technologies

Top funds holding Moleculin Biotech

Armistice Capital
Vanguard Group
LPL Financial
Geode Capital Management
BlackRock
BlackRock
Renaissance Technologies
Atticus Wealth Management
Tower Research Capital
Newbridge Financial Services Group
Morgan Stanley
Bank of America Corporation
Sandy Spring Bank
CVA Family Office
Advisor Group Holdings

View all funds holding Moleculin Biotech